Skip NavigationSkip to Content

Contribution of IRF-3 mediated IFN beta production to DNA vaccine dependent cellular immune responses

  1. Author:
    Shirota, H.
    Petrenko, L.
    Hattori, T.
    Klinman, D. M.
  2. Author Address

    Shirota, Hidekazu, Petrenko, Lev, Klinman, Dennis M.] NCI, Expt Immunol Lab, Frederick, MD 21702 USA. [Shirota, Hidekazu, Hattori, Toshio] Tohoku Univ, Sch Med, Dept Resp & Infect Dis, Sendai, Miyagi 980, Japan.
    1. Year: 2009
  1. Journal: Vaccine
    1. 27
    2. 15
    3. Pages: 2144-2149
  2. Type of Article: Article
  1. Abstract:

    The mechanism(s) by which DNA vaccines activate Ag-specific cellular immune responses is incompletely understood. Current findings indicate that IRF-3 plays an important role in this process. The IRF-3 dependent signaling pathway is triggered by the presence of intracytoplasmic DNA, and culminates in the production of type 1 IFNs. DNA vaccination of IRF-3 KO mice elicits a strong Ag-specific humoral response, yet CD4 and CD8 T cell responses (including the production of Th1, Th2 and Th17 cytokines) are severely impaired. Although expression of the immunogenic protein encoded by the DNA vaccine was similar in IRF-3 KO vs wild type mice, antigen presentation was severely impaired in the KO animals. This defect was remedied by the co-delivery of an IFN beta encoding plasmid. These findings suggest that the IRF-3/IFN beta pathways are key to the induction of cellular immunity following DNA vaccination. Published by Elsevier Ltd.

    See More

External Sources

  1. DOI: 10.1016/j.vaccine.2009.01.134
  2. PMID: 19356618

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel